Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature

[1]  J. Cornelissen,et al.  Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. , 2019, The Journal of antimicrobial chemotherapy.

[2]  J. Camargo,et al.  Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.

[3]  H. Eguchi,et al.  Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society , 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  J. Meis,et al.  Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management , 2019, Journal of fungi.

[5]  C. Beigelman-Aubry,et al.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  C. Ensor,et al.  Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients , 2017, Antimicrobial Agents and Chemotherapy.

[7]  D. Hagiwara,et al.  Drug Sensitivity and Resistance Mechanism in Aspergillus Section Nigri Strains from Japan , 2017, Antimicrobial Agents and Chemotherapy.

[8]  S. Ito,et al.  Invasive pulmonary aspergillosis due to azole‐resistant Aspergillus lentulus , 2017, Pediatrics international : official journal of the Japan Pediatric Society.

[9]  D. Kowalski,et al.  Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults , 2016, Clinical pharmacology in drug development.

[10]  S. Kawasaki,et al.  Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  D. Denning,et al.  Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Ichiyama,et al.  Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[14]  Nina Singh,et al.  Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  J. Meis,et al.  Passive Surveillance for Azole-Resistant Aspergillus fumigatus, United States, 2011–2013 , 2014, Emerging infectious diseases.

[16]  D. Samuel,et al.  Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era , 2013, Clinical transplantation.

[17]  S. Mochida,et al.  Acute liver failure in Japan: definition, classification, and prediction of the outcome , 2012, Journal of Gastroenterology.

[18]  M. Makuuchi,et al.  The risk factors of fungal infection in living-donor liver transplantations , 2012, Journal of hepato-biliary-pancreatic sciences.

[19]  S. Kawachi,et al.  Pharmacokinetics of mizoribine in adult living donor liver transplantation. , 2012, Transplantation proceedings.

[20]  Y. Takikawa,et al.  Diagnostic criteria of acute liver failure: A report by the Intractable Hepato‐Biliary Diseases Study Group of Japan , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  T. Hibi,et al.  Current progress in ABO‐incompatible liver transplantation , 2010, European journal of clinical investigation.

[22]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  I. Endo,et al.  A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation. , 2007, Transplantation proceedings.

[24]  T. Hirai,et al.  Risk factors for invasive aspergillosis in living donor liver transplant recipients , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  C. Hughes,et al.  Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  P. Martín-Dávila,et al.  Risk factors for invasive aspergillosis in liver transplant recipients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  ohn,et al.  VORICONAZOLE VERSUS AMPHOTERICIN B FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS , 2002 .

[28]  Nina Singh,et al.  Invasive aspergillosis in transplant recipients. , 1999, Medicine.

[29]  E. Reed,et al.  Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. , 1995, The Journal of thoracic and cardiovascular surgery.